01:56:08 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Arev Nanotec Brands Inc
Symbol AREV
Shares Issued 9,457,808
Close 2020-04-28 C$ 0.15
Market Cap C$ 1,418,671
Recent Sedar Documents

ORIGINAL: AREV Receives 45 Day Extension to File Quarterly Financial Statements and MD&A

2020-04-28 16:30 ET - News Release

(via TheNewswire)



VANCOUVER, BC - TheNewswire - April 28 , 2020 - AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVD) ("AREV Brands") announces the Company has provided an update on the status of the filing of its:

  • - annual audited financials statements, the accompanying management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the filings ended December 31, 2019; and

    - quarterly financial statements, the accompanying management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the filings first quarter ended March 31, 2020 .

On March 18, 2020, the Canadian Securities Administrators (CSA) announced that they will provide issuers with a 45-day filing extension for filings required on or before June 1, 2020 to allow issuers the time needed to focus on the many other business and financial reporting implications of COVID-19. The Company will rely on this exemption with respect to the quarterly filings in accordance with BC Instrument 51-515, Temporary Exemption from Certain Corporate Finance Requirements.

Members of the Company's management and other insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207. The Company expects to file the Documents on or before the end of the available 45 extension period. An update on material business developments since the filing of the Company's interim financial reports has been provided in prior press releases.

For further information, contact Mike Withrow, mike@AREVBrands.com 778-929-6536.

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Inc.
AREV NanoTec Brands Inc. ("AREV") produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV's model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada. The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company' s Management 's Discussion and Analysis under the Company's profile on www.sedar.com.

Copyright (c) 2020 TheNewswire - All rights reserved.

© 2024 Canjex Publishing Ltd. All rights reserved.